Tag:
co-pay
Latest Headlines
Latest Headlines
Health plans sue Big Pharma over co-pay coupons
Pharma's co-pay discounts have their fans--patients, certainly, but they also have their detractors.
AZ's Crestor scored points, but didn't beat Lipitor
AstraZeneca's press release on the SATURN trial is an object lesson in how to spin a study that didn't turn out as expected: Focus on the positive. The company announced SATURN showed "intensive"
AZ launches Crestor co-pay card to battle Lipitor copies
Joining the growing number of drugmakers using discount cards and coupons to retain patients, AstraZeneca ( $AZN ) has launched a co-pay help card for its statin drug Crestor . The cholesterol remedy
Co-pay cards to hike drug costs $32B, report says
Co-pay discounts may be good for patients and good for branded drugmakers, but they're not so good for the payers in the middle. So says a new study from pharmacy benefits managers, which concluded
Docs blame reimbursement, complexity, cost-benefit for Provenge uptake
Dendreon ( $DNDN ) may face a lot more than cost density in persuading doctors to adopt its prostate cancer vaccine Provenge. Oncologists and urologists said reimbursement issues have contributed to
Co-pay help boosts drugs, scares payers
Coupons work. That's what drugmakers have discovered from the co-pay assistance they've been offering to shore up demand for aging branded drugs (Pfizer's statin Lipitor), create demand for new ones
